The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.
The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.
Next generation sequencing is also known as non-Sanger based high throughput DNA sequencing technology. This term is particularly used for defining advanced and modern sequencing technologies such as Roche 454 Sequencing, Illumina (Solexa) Sequencing, Proton/PGM sequencing, and SOLiD sequencing among others. Billions of DNA strands are chained in parallel that provide considerable more throughput. The clinical oncology-next generation sequencing market is thus making use of such new sequencing technologies for profiling cancer. The leading players in the global market are concentrating more on acquisitions, mergers, and strategic joint ventures. This has thus helped the developing nations to offer support to set up new centers for research and development activities.
Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1232
Global Clinical Oncology Next-generation Sequencing Market – Notable Developments
Some of the notable developments in the global clinical oncology-next generation sequencing market are given below:
- In April 2017, Genomatix Inc. announced that the company has successfully acquired funding from the Bavarian Ministry of Economic Affairs and Media, Energy, and Technology for the Multiple Integration and Data Annotation Study (MIDAS) project. The aim of the project and funding is to enhance the characterization of rare diseases such as cancer in children and devise effective treatment.
- In August 2019, Agilent Technologies, a prominent name in the global clinical oncology-next generation sequencing market announced that the company has successfully taken over BioTek Instruments. This acquisition is expected to bolster the production capacity of Agilent Technologies. The aim of the acquisition was to complement the research in the field of next generation sequencing by developing effective technologies for the same.
Some of the leading vendors in the global next-generation sequencing market are:
- GATC Biotech Ag
- Oxford Nanopore Technologies Ltd.
- Macrogen Inc.
- Life technologies Corp.
- DNASTAR Inc.
- Myriad Genetics
- Exosome Diagnostics
- Biomatters Ltd.
- BGI (Beijing Genomics Institute)
- Qiagen NV, Perkin Elmer, Inc.
- Pacific Bioscience, Inc.
- Partek, Inc.
- Bio-Rad Laboratories, Inc.
Global Clinical Oncology Next-generation Sequencing Market – Drivers and Restraints
Among the several growth influencing factors for the clinical oncology-next generation sequencing market, the biggest factor is the increasing adoption of genomic-centric pharmacology in the treatment of cancer. The clinical oncology-next generation sequencing market makes use of the most advanced genomic techniques and technologies to investigate the genetic changes that occur due to the spreading of cancer in the body. The rapid development and innovations in this segment is thus driving the overall growth of the global clinical oncology-next generation sequencing market.
Get Discount on the Latest Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=1232
In addition to this, there has been a considerable rise in investments and funding to the research and development centers concentrating on finding new solutions in sequencing. This factor coupled with expanding healthcare budgets of several developed nations is also providing a big help to the global clinical oncology-next generation sequencing market.
Moreover, the practicing medical professionals and doctors are now familiar with clinical oncology-next generation sequencing and are increasingly using the same for diagnosis and treatment of cancer. This has not only spreading the awareness among the common masses but also helping to scale up the uptake of the global market. Oncologists these days are more reliant clinical oncology-next generation sequencing to select drugs or their combination for treating patients.
Global Clinical Oncology Next-generation Sequencing Market – Geographical Outlook
There are five main geographical segments of the global clinical oncology-next generation sequencing market viz. Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. Of these, the global market is expected to be dominated by North America over the course of the given forecast period of 2018 to 2028. This growth of the market is due to heavy spending on the development of new R&D facilities that work on clinical oncology-next generation sequencing. In addition to this, the presence of several leading players in the global market has also worked in favor for the growth of the North America market.
Global Clinical Oncology Next-generation Sequencing Market Segmentation:
Product Type
- NGS Pre-Sequencing
- Sequencing
- NGS Data Analysis
- Primary, Secondary & Tertiary Data Analysis
Application
- Academic & Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
The 5-point growth formula includes the following points:
- Current and Future Threats
- Accurate Trend Analysis
- Regional Assessment
- Industrial Analogy
- COVID-19 Impact
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1232
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Regional Assessment
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
Industrial Analogy
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
COVID-19 Impact
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site: https://www.tmrresearch.com/